Syndax Pharmaceuticals Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 5,096.1% | 3,785.6% | 4,420.3% | 4,638.4% | 5,164.3% | 1,733.6% | 5,311.3% | 5,100.3% | 4,807.7% | 0.0% | – | – | – | – | – | – | – | 0.3% | – | – | – | 0.1% | – | – | – | – | – | – | – | 50.0% | – | 1,266.8% | 0.0% | 10.8% | 4.4% | 3.4% | 4.6% | -2.3% | 4.1% | 4.4% | 2.5% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.7% | 100.0% | 100.0% | 100.0% | 99.9% | – | – | – | – | – | – | – | 50.0% | – | 100.0% | 100.0% | 100.0% | 95.6% | 96.6% | 95.4% | 102.3% | 95.9% | 95.6% | 97.5% | |
| 4,024.3% | 2,778.4% | 3,131.8% | 3,233.4% | 3,996.1% | 1,391.4% | 4,047.2% | 3,918.5% | 3,719.0% | 4,163.4% | 2,976.0% | 3,242.7% | 2,618.2% | 2,500.5% | 2,523.0% | 2,887.3% | 3,801.6% | 4,084.7% | 5,770.4% | 4,451.5% | 206.9% | 18.9% | – | – | – | – | – | – | – | 10,284.7% | – | 1,390.1% | 567.8% | 853.2% | 307.5% | 163.9% | 122.7% | 114.8% | 90.7% | 93.5% | 103.9% | |
| 1,071.8% | 974.4% | 1,288.5% | 1,404.9% | 1,168.2% | 342.2% | 1,264.1% | 1,181.8% | 1,088.4% | 1,024.2% | 1,031.9% | 913.7% | 951.2% | 1,337.6% | 1,561.2% | 1,595.3% | 1,536.7% | 1,241.6% | 1,496.6% | 1,541.4% | 55.0% | 5.5% | – | – | – | – | – | – | – | 8,235.6% | – | 830.3% | 248.8% | 490.8% | 204.7% | 115.4% | 97.9% | 72.9% | 57.9% | 57.1% | 69.0% | |
| 5,096.1% | 3,752.8% | 4,420.3% | 4,638.4% | 5,164.3% | 1,733.6% | 5,311.3% | 5,100.3% | 4,807.4% | 5,187.6% | 4,007.9% | 4,156.5% | 3,569.4% | 3,838.2% | 4,084.2% | 4,482.6% | 5,338.3% | 5,326.3% | 7,267.0% | 5,992.9% | 261.9% | 24.4% | – | – | – | – | – | – | – | 14,534.5% | – | 2,220.5% | 816.6% | 1,354.8% | 513.5% | 279.3% | 220.6% | 193.6% | 148.7% | 150.5% | 174.5% | |
| -4,996.1% | -3,652.8% | -4,320.3% | -4,538.4% | -5,064.3% | -1,633.6% | -5,211.3% | -5,000.3% | -4,707.4% | -5,087.6% | -3,907.9% | -4,056.5% | -3,469.4% | -3,738.2% | -3,984.2% | -4,382.6% | -5,238.3% | -5,226.3% | -7,167.0% | -5,892.9% | -161.9% | 75.6% | – | – | – | – | – | – | – | -14,534.5% | – | -2,120.5% | -716.6% | -1,254.8% | -417.9% | -182.7% | -125.2% | -91.3% | -52.7% | -54.9% | -77.1% | |
| 87.9% | 313.4% | 84.9% | 95.1% | 134.8% | 119.1% | 125.3% | 121.1% | 128.8% | 511.1% | 119.3% | 132.2% | 104.2% | 413.4% | 118.5% | 168.3% | 167.5% | 167.1% | 164.4% | 167.3% | 5.2% | 0.0% | – | – | – | – | – | – | – | 11.8% | – | 1.3% | 0.2% | 62.6% | 40.2% | 20.7% | 18.1% | 77.0% | 18.3% | 17.4% | 33.9% | |
| -4,907.9% | -3,545.9% | -4,252.8% | -4,471.8% | -4,946.9% | -1,601.3% | -5,118.2% | -4,851.7% | -4,574.7% | -4,957.1% | -3,773.6% | -3,935.6% | -3,385.0% | -3,684.2% | -4,020.1% | -4,501.8% | -5,392.3% | -5,374.5% | -7,314.8% | -6,044.9% | -166.8% | 76.0% | – | – | – | – | – | – | – | -13,521.1% | – | -1,944.7% | -673.0% | -1,226.2% | -423.3% | -189.3% | -132.4% | -99.3% | -65.8% | -67.8% | -87.6% | |
| 22.6% | -33.1% | -84.9% | -95.1% | -134.8% | 13.2% | -109.0% | -101.3% | -90.5% | -94.7% | 47.5% | -73.1% | -104.2% | -117.4% | 113.2% | 158.0% | -6.1% | -5.5% | 149.3% | 154.1% | 4.9% | 0.0% | – | – | – | – | – | – | – | 931.5% | – | – | 0.0% | – | – | – | – | – | – | – | – | |
| -4,907.9% | -3,545.9% | -4,252.8% | -4,471.8% | -4,946.9% | -1,601.3% | -5,118.2% | -4,851.7% | -4,574.7% | -4,957.1% | -3,773.6% | -3,935.6% | -3,385.0% | -3,684.2% | -4,020.1% | -4,501.8% | -5,392.3% | -5,374.5% | -7,314.8% | -6,044.9% | -166.8% | 76.0% | – | – | – | – | – | – | – | -13,521.1% | – | -1,944.7% | -673.0% | -1,226.2% | -423.3% | -189.3% | -132.4% | -99.3% | -65.8% | -67.8% | -87.6% | |
| -4,996.1% | -3,619.7% | -4,318.4% | -4,514.4% | -5,013.8% | -1,653.1% | -5,195.0% | -4,980.5% | -4,669.1% | -4,992.9% | -3,726.1% | -3,935.6% | -3,371.8% | -3,620.8% | -3,895.5% | -4,327.7% | -5,218.7% | -5,226.3% | -7,146.2% | -5,875.2% | -161.5% | 76.1% | – | – | – | – | – | – | – | -13,508.8% | – | -1,943.3% | -672.8% | -1,163.6% | -417.9% | -168.4% | -114.3% | -22.4% | -47.5% | -50.4% | -53.7% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.